Log In
Print this Print this

ViaDor-hPTH (1-34) (formerly ViaDerm-hPTH (1-34))

  Manage Alerts
Collapse Summary General Information
Company Syneron Medical Ltd.
DescriptionPeptide fragment of human parathyroid hormone delivered using the ViaDor transdermal drug delivery system
Molecular Target Parathyroid hormone (PTH) receptor
Mechanism of ActionParathyroid hormone receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today